Signaling Pathways
-
B1527 GW4064Target: FXRSummary: Non-steroidal FXR agonist,potent and selective
-
B1639 Ridaforolimus (Deforolimus, MK-8669)Target: mTORSummary: MTOR inhibitor
-
B1465 Plerixafor 8HCl (AMD3100 8HCl)Target: CXCRSummary: CXCR4 antagonist
-
B1036 MLN49245 CitationTarget: NAE|Ubiquitin-activating Enzyme E1|SUMOylationSummary: NAE inhibitor
-
B1307 SJB3-019ATarget: USPSummary: Usp1 inhibitor
-
B1614 Solifenacin succinateTarget: M3 ReceptorsSummary: Muscarinic receptor antagonist
-
B1600 Darifenacin HBrTarget: M3 ReceptorsSummary: Selective M3 muscarinic receptor antagonist
-
B1867 Verapamil HCl1 CitationTarget: Voltage-gated Calcium Channels (CaV)Summary: L-type calcium channel blocker
-
B2092 DoxifluridineSummary: oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU)
-
B1490 Quetiapine Fumarate1 CitationTarget: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 ReceptorsSummary: Dopamine receptor antagonist